Skip to main content
OpenTrials
Completed

NCT Number: NCT05741554

Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule

Investigators studied a population of 28 low grade serous ovarian carcinoma treated in Hospices civils de Lyon between 2000 and 2022. The primary objective is to determinate the rate of myometrial involvement by the cancer at pathology examination. Then, investigators compared patients with or without myometrial involvement : survival parameters, predictive factors of myometrial involvement (age, CA 125 level, surgery characteristics, pathology characteristics).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Serous Ovarian Carcinoma Low Grade Serous Ovarian Carcinoma

Sex eligibility

Female

Study type

Observational

Primary location

Hospices civils de Lyon

Lyon, 69000, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria :
  • 18 years old or more
  • low grade serous ovarian cancer (MDACC classification)
  • Grade 1 serous ovarian carcinoma (Silverberg classification)
  • Exclusion Criteria :
  • no sufficient data available
  • grade 2 and 3 serous ovarian carcinoma

Treatment and study plan

Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.

Other

Presence of uterine myometrial metastasis at pathology examination after cytoreductive surgery

Primary outcomes

  1. Percentage of myometrial involvement

    Time frame: After pathology examination, average 2 to 3 weeks after cytoreductive surgery

    Myometrial involvement after pathology examination

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Acronym: LOGYST

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 23, 2023
Registry last updated
Feb 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.